Year in Review: Alzheimer’s Disease

(MedPage Today) — News about Alzheimer’s rose to the forefront in 2025, as the FDA approved the first diagnostic blood test and drugmakers reported 3-year outcomes for both anti-amyloid drugs, lecanemab (Leqembi) and donanemab (Kisunla).
The…